News

Fierce Pharma5h
‘Abuse of power’: Senators call out ‘shady tactics’ after investigating Pfizer, Lilly DTC platforms
After a nine-month investigation into direct-to-consumer telehealth platforms launched by Eli Lilly and Pfizer, a group of ...
Fierce Pharma9h
After recall, Pfizer warns of 'near-term stock out' of penicillin product used to treat syphilis in pregnant women
The move is expected to cause a “near-term stock out of Bicillin L-A,” Pfizer said in its statement, with the drugmaker now ...
Fierce Pharma9h
Leo Pharma's slow response to app lapse scolded by UK marketing watchdog
Leo Pharma’s inaccurate Innohep app has prompted a slap-down from the PMCPA. The U.K. | Leo Pharma’s inaccurate Innohep app ...
Fierce Pharma8h
Novartis’ Pluvicto finally picks up speed, delivers another trial win in early prostate cancer
Novartis is launching a $10 billion share buyback to be completed by year-end 2027 as new drug launches accelerate. | ...
Fierce Pharma10h
AI adoption is an 'immediate priority' to most Big Pharmas, report finds
As advances in artificial intelligence technology continue to offer enticing benefits to industries across the board, pharma ...
Fierce Pharma8h
Bristol Myers, Pfizer offer Eliquis at a discount through DTC online program
Taking a page from Eli Lilly and Novo Nordisk, who have launched online programs to sell their diabetes and obesity drugs ...
Fierce Pharma4h
FDA advisors spurn GSK’s Blenrep comeback dreams on safety, trial concerns
On a quest to bring its multiple myeloma antibody-drug conjugate (ADC) Blenrep back to the U.S. | Members of the FDA's Oncologic Drugs Advisory Committee voiced concerns with ocular toxicity side ...